Article Information
History
- June 8, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Rujipas Sirijatuphata,
- Weerawat Manosuthib,
- Suvimol Niyomnaithamc,d,
- Andrew Owene,
- Katherine K. Copelandf,
- Lantharita Charoenpongb,
- Manoch Rattanasompattikulg,
- Surakameth Mahasirimongkolh and
- Kulkanya Chokephaibulkitd,i,*
- aDepartment of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand
- bBamrasnaradura Infectious Diseases Institute, Ministry of Public Health, Nonthaburi, Thailand
- cDepartment of Pharmacology, Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand
- dSiriraj Institute of Clinical Research (SICRES), Mahidol University, Thailand
- eInstitute of Systems, Molecular and Integrative Biology, University of Liverpool, United Kingdom
- fMahidol University International College, Salaya, Nakhon Pathom, Thailand
- gMedical Department, Golden Jubilee Medical Centre, Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand
- hDivision of Genomic Medicine and Innovation Support, Department of Medical Sciences, Ministry of Public Health, Nonthaburi, Thailand
- iDepartment of Paediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand
- ↵*Corresponding author:
Kulkanya Chokephaibulkit, MD, 2 Wanglang Road, Bangkoknoi, Bangkok 10700, Thailand, Tel: (+66) 2-4141899; Fax: (+66) 2-4128243, E-mail: kulkanya.cho{at}mahidol.ac.th.
Posted June 08, 2022.
Early Treatment of Favipiravir in COVID-19 Patients Without Pneumonia: A Multicentre, Open-Labelled, Randomized Control Study
